Keywords
Cancer
Molecular mechanisms
Development
Submitted : 2024-10-23
Accepted : 2024-11-07
Published : 2024-11-22
Abstract
MicroRNAs (miRNAs) are small noncoding RNAs strongly implicated in the control of gene expression post-transcriptionally. They account for a wide range of functions recognized as characteristic cancer signatures, including apoptosis, invasion, metastasis, and proliferation. MicroRNA-21 (miR-21) is well-recognized for its crucial role in various solid tumors, such as glioblastoma, ovarian cancer, non-small cell lung cancer, and many others. In numerous malignancies, miR-21 selectively targets multiple key components and influences a broad spectrum of cellular processes, including cancer stemness and cell death. The miR-21 gene exhibits both cancer-promoting and cancer-suppressing properties, though most research highlights its facilitative role in cancer development. MiR-21 mediates PTEN reduction to enhance PI3K/Akt signaling in cancer progression. Its overexpression inhibits apoptosis and significantly promotes pro-survival autophagy. The notable upregulation of miR-21 in cancerous tissues positions it as a promising cancer biomarker with considerable diagnostic and prognostic potential. This study aims to define the functional roles of miR-21 as a crucial regulator in various cancers and its potential as a therapeutic target.
References
Zhao Z, Sun W, Guo Z, et al., 2020, Mechanisms of lncRNA/microRNA Interactions in Angiogenesis. Life Sciences, 254: 116900. https://doi.org/10.1016/j.lfs.2019.116900
Sharma MG, 2022, RNA Transcription, in Kar D, Sarkar S (eds), Genetics Fundamentals Notes. Springer, Singapore, 491–535. https://doi.org/10.1007/978-981-16-7041-1_10
Knutson BA, McNamar R, Rothblum LI, 2020, Dynamics of the RNA Polymerase I TFIIF/TFIIE-Like Subcomplex: A Mini-Review. Biochem Soc Trans, 48(5): 1917–1927. https://doi.org/10.1042/BST20190848
Rajendra KC, Cheng R, Zhou S, et al., 2024, Evidence of RNA Polymerase III Recruitment and Transcription at Protein-Coding Gene Promoters. Mol Cell, 2024 Oct 5: S1097-2765(24)00771-8. https://doi.org/10.1016/j.molcel.2024.09.019
Seo Y, Kim SS, Kim N, et al., 2020, Development of a miRNA-Controlled Dual-Sensing System and Its Application for Targeting miR-21 Signaling in Tumorigenesis. Exp Mol Med, 52: 1989–2004. https://doi.org/10.1038/s12276-020-00537-z
Meškytė EM, Keskas S, Ciribilli Y, 2020, MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis. Int J Mol Sci, 21(20): 7710. https://doi.org/10.3390/ijms21207710
Pekarek L, Torres-Carranza D, Fraile-Martinez O, et al., 2023, An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis. Int J Mol Sci, 24(8): 7268. https://doi.org/10.3390/ijms24087268
Shinde SS, Ahmed S, Malik JA, et al., 2023, Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment. Biology, 12(3): 467. https://doi.org/10.3390/biology12030467
Messina S, 2024, The RAS Oncogene in Brain Tumors and the Involvement of let-7 MicroRNA. Mol Biol Rep, 51: 531. https://doi.org/10.1007/s11033-024-09439-z
Štefánik P, Morová M, Herichová I, 2024, Impact of Long-Lasting Environmental Factors on Regulation Mediated by the miR-34 Family. Biomedicines, 12(2): 424. https://doi.org/10.3390/biomedicines12020424
Far BF, Vakili K, Fathi M, et al., 2023, The Role of MicroRNA-21 (miR-21) in Pathogenesis, Diagnosis, and Prognosis of Gastrointestinal Cancers: A Review. Life Sciences, 316: 121340. https://doi.org/10.1016/j.lfs.2022.121340
Jie Z, Li P, Wu H, et al., 2024, Polymorphisms in miR-17-92 Cluster Promoter Region is Associated with Risk and Prognosis of Endometrial Cancer. Medicine (Baltimore), 103(33): e39326. https://doi.org/10.1097/MD.0000000000039326
Wu Y, Hong Q, Lu F, et al., 2023, The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis. Mol Diagn Ther, 27(3): 283–301. https://doi.org/10.1007/s40291-023-00641-6
Arghiani N, Matin MM, 2021, miR-21: A Key Small Molecule with Great Effects in Combination Cancer Therapy. Nucleic Acid Therapeutics, 31(4): 271–283. https://doi.org/10.1089/nat.2020.091
Abadi AJ, Zarrabi A, Gholami MH, et al., 2021, Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers. Biomolecules, 11(2): 304. https://doi.org/10.3390/biom11020304
Singh A, Singh AK, Giri R, et al., 2021, The Role of microRNA-21 in the Onset and Progression of Cancer. Future Medicinal Chemistry, 13(21): 1885–1906. https://doi.org/10.4155/fmc-2021-0096
Najjary S, Mohammadzadeh R, Mokhtarzadeh A, et al., 2020, Role of miR-21 as an Authentic Oncogene in Mediating Drug Resistance in Breast Cancer. Gene, 738: 144453. https://doi.org/10.1016/j.gene.2020.144453
Hashemi M, Mirdamadi MSA, Talebi Y, et al., 2023, Pre-Clinical and Clinical Importance of miR-21 in Human Cancers: Tumorigenesis, Therapy Response, Delivery Approaches and Targeting Agents. Pharmacological Research, 187: 106568. https://doi.org/10.1016/j.phrs.2022.106568
Surina, Fontanella RA, Scisciola L, et al., 2021, miR-21 in Human Cardiomyopathies. Front Cardiovasc Med, 8: 767064. https://doi.org/10.3389/fcvm.2021.767064
Jiang R, Chen X, Ge S, et al., 2021, MiR-21-5p Induces Pyroptosis in Colorectal Cancer via TGFBI. Front Oncol, 10: 610545. https://doi.org/10.3389/fonc.2020.610545
Lv X, Liang J, Wang Z, 2024, MiR-21-5p Reduces Apoptosis and Inflammation in Rats with Spinal Cord Injury Through PI3K/AKT Pathway. Panminerva Medica, 66(3): 256–265. https://doi.org/10.23736/S0031-0808.20.03974-9
Tang Q, Zhang Y, Yue L, et al., 2022, Ssc-MiR-21-5p and Ssc-MiR-615 Regulates the Proliferation and Apoptosis of Leydig Cells by Targeting SOX5. Cells, 11(14): 2253. https://doi.org/10.3390/cells11142253
Chen J, Chen J, Cheng Y, et al., 2020, Mesenchymal Stem Cell-Derived Exosomes Protect Beta Cells Against Hypoxia-Induced Apoptosis via miR-21 by Alleviating ER Stress and Inhibiting p38 MAPK Phosphorylation. Stem Cell Res Ther, 11: 97. https://doi.org/10.1186/s13287-020-01610-0
D’Souza LC, Mishra S, Chakraborty A, et al., 2020, Oxidative Stress and Cancer Development: Are Noncoding RNAs the Missing Links? Antioxidants & Redox Signaling, 33(17): 1209–1229. https://doi.org/10.1089/ars.2019.7987
Giordo R, Ahmadi FAM, Husaini NA, et al., 2024, MicroRNA 21 and Long Non-Coding RNAs Interplays Underlie Cancer Pathophysiology: A Narrative Review. Noncoding RNA Res, 9(3): 831–852. https://doi.org/10.1016/j.ncrna.2024.03.013
Jiang Z, Hou Z, Li L, et al., 2021, Exosomal circEPB41L2 Serves as a Sponge for miR-21-5p and miR-942-5p to Suppress Colorectal Cancer Progression by Regulating the PTEN/AKT Signalling Pathway. European Journal of Clinical Investigation, 51(9): e13581. https://doi.org/10.1111/eci.13581
Veziroglu EM, Mias GI, 2020, Characterizing Extracellular Vesicles and Their Diverse RNA Contents. Front Genet, 11: 700. https://doi.org/10.3389/fgene.2020.00700
Jin XH, Lu S, Wang AF, 2020, Expression and Clinical Significance of miR-4516 and miR-21-5p in Serum of Patients with Colorectal Cancer. BMC Cancer, 20: 241. https://doi.org/10.1186/s12885-020-06715-6
Ghareib AF, Mohamed RH, Abd El-Fatah AR, et al., 2020, Assessment of Serum MicroRNA-21 Gene Expression for Diagnosis and Prognosis of Colorectal Cancer. J Gastrointest Cancer, 51(3): 818–823. https://doi.org/10.1007/s12029-019-00306-w
Xue C, Chen C, Gu X, et al., 2021, Progress and Assessment of lncRNA DGCR5 in Malignant Phenotype and Immune Infiltration of Human Cancers. Am J Cancer Res, 11(1): 1–13.
Li X, Zhou S, Fan T, et al., 2020, lncRNA DGCR 5/miR‑27a‑3p/BNIP3 Promotes Cell Apoptosis in Pancreatic Cancer by Regulating the p38 MAPK Pathway. Int J Mol Med, 46(2): 729–739. https://doi.org/10.3892/ijmm.2020.4632
Li B, Cao Y, Sun M, et al., 2021, Expression, Regulation, and Function of Exosome-Derived miRNAs in Cancer Progression and Therapy. FASEB J, 35(10): e21916. https://doi.org/10.1096/fj.202100294RR
Lin K, Zhu J, Hu C, et al., 2020, Comprehensive Analysis of the Prognosis for Chromobox Family in Gastric Cancer. J Gastrointest Oncol, 11(5): 932–951. https://doi.org/10.21037/jgo-20-208
Ghaemi S, Fekrirad Z, Zamani N, et al., 2022, Non-Coding RNAs Enhance the Apoptosis Efficacy of Therapeutic Agents Used for the Treatment of Glioblastoma Multiform. J Drug Target, 30(6): 589–602. https://doi.org/10.1080/1061186X.2022.2047191
Darvish L, Bahreyni Toossi MT, Azimian H, et al., 2023, The Role of MicroRNA-Induced Apoptosis in Diverse Radioresistant Cancers. Cell Signal, 104: 110580. https://doi.org/10.1016/j.cellsig.2022.110580
Nguyen T-T, Ung T-T, Li S, et al., 2021, Lithocholic Acid Induces miR21, Promoting PTEN Inhibition via STAT3 and ERK-1/2 Signaling in Colorectal Cancer Cells. Int J Mol Sci, 22(19): 10209. https://doi.org/10.3390/ijms221910209
Zhao W, Ning L, Wang L, et al., 2021, miR-21 Inhibition Reverses Doxorubicin-Resistance and Inhibits PC3 Human Prostate Cancer Cells Proliferation. Andrologia, 53(5): e14016. https://doi.org/10.1111/and.14016
Almatroodi SA, Almatroudi A, Khan AA, et al., 2023, Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy through the Modulation of Signal Transduction Pathways. Int J Mol Sci, 24(11): 9719. https://doi.org/10.3390/ijms24119719
Li J, Huang L, He Z, et al., 2021, Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway. Front Cell Dev Biol, 9: 643525. https://doi.org/10.3389/fcell.2021.643525
Ding Y, Hou Y, Liu Y, et al., 2021, Prospects for miR-21 as a Target in the Treatment of Lung Diseases. Curr Pharm Des, 27(3): 415–422. https://doi.org/10.2174/1381612826999200820160608
Li R, Wen YX, Geng YQ, et al., 2019, miR-21a Inhibits Decidual Cell Apoptosis by Targeting Pdcd4. Genes Dis, 8(2): 171–180. https://doi.org/10.1016/j.gendis.2019.09.013
Jiang NJ, Yin YN, Lin J, et al., 2023, MicroRNA-21 in Gynecological Cancers: From Molecular Pathogenesis to Clinical Significance. Pathol Res Pract, 248: 154630. https://doi.org/10.1016/j.prp.2023.154630
Sabo AA, Dudau M, Constantin GL, et al., 2021, Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy. Front Pharmacol, 12: 652074. https://doi.org/10.3389/fphar.2021.652074
Mahmoud MM, Sanad EF, Hamdy NM, 2021, MicroRNAs’ Role in the Environment-Related Non-Communicable Diseases and Link to Multidrug Resistance, Regulation, or Alteration. Environ Sci Pollut Res Int, 28(28): 36984–37000. https://doi.org/10.1007/s11356-021-14550-w
Wang M, Wang Y, Tian X, et al., 2023, Diagnostic and Predictive Value of Liquid Biopsy-Derived Exosome miR-21 for Breast Cancer: A Systematic Review and Meta-Analysis. Expert Rev Mol Diagn, 23(4): 315–324. https://doi.org/10.1080/14737159.2023.2195552
Li K, Gong Q, Xiang XD, et al., 2023, HNRNPA2B1-Mediated m6A Modification of lncRNA MEG3 Facilitates Tumorigenesis and Metastasis of Non-Small Cell Lung Cancer by Regulating miR-21-5p/PTEN Axis. J Transl Med, 21(1): 382. https://doi.org/10.1186/s12967-023-04190-8
Li J, Chen H, Sun G, et al., 2023, Role of miR-21 in the Diagnosis of Colorectal Cancer: Meta-Analysis and Bioinformatics. Pathol Res Pract, 248: 154670. https://doi.org/10.1016/j.prp.2023.154670
Chen C, Demirkhanyan L, Gondi CS, 2024, The Multifaceted Role of miR-21 in Pancreatic Cancers. Cells, 13(11): 948. https://doi.org/10.3390/cells13110948
Bilan F, Amini M, Doustvandi MA, et al., 2024, Simultaneous Suppression of miR-21 and Restoration of miR-145 in Gastric Cancer Cells; A Promising Strategy for Inhibition of Cell Proliferation and Migration. Bioimpacts, 14(2): 27764. https://doi.org/10.34172/bi.2023.27764
Habel A, Nassar F, Itani M, et al., 2023, Mir-21 and Mir-125b as Theranostic Biomarkers for Epithelial Ovarian Cancer in Tunisian Women. Afr Health Sci, 23(2): 256–264. https://doi.org/10.4314/ahs.v23i2.29
Angel CZ, Stafford MYC, McNally CJ, et al., 2023, MiR-21 is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. Cancers (Basel), 15(4): 1291. https://doi.org/10.3390/cancers15041291